arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

MeiraGTx Holdings plc

MGTX
$13.07 ▲ +0.28 (+2.15%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
10 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

MeiraGTx Holdings plc faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.1B
Dividend Yield
Revenue Growth 144.6%
Op. Margin -130.2%
ROIC 1829.2%
FCF / Share $-0.62
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$81.39M
↑ +144.6%
Net Income Profit after all expenses
$-114.20M
↑ +22.7%
Operating Margin Operating profit as % of sales
-130.2%
↑ +73.6% 1th
FCF / Share Free cash flow per share
$-0.62
↑ +60.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
2
Financial Health
32
Cash Quality
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 37 quarters